MedTrace Logo

Triglyceride Rich Lipoproteins and Platelet Activation in Type 2 Diabetes

NCT03561571 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2025-08-22

No results posted yet for this study

Summary

To investigate in vitro the effect of triglyceride rich lipoproteins (TGRL) obtained in type 2 diabetic women in the fasting state and following a randomized isocaloric lipid rich breakfast on control human platelets

Randomized Comparison of butter versus chocolate spread in 2 groups of 15 patients

Conditions

  • Type2 Diabetes

Interventions

OTHER

butter based breakfast

ingestion of proteins : 5 g, lipids 20 g, glucides 57 g

OTHER

Chocolate spread based breakfast

ingestion of proteins 7 g, lipids 20 g, glucides 56 g

Sponsors & Collaborators

  • Hospices Civils de Lyon

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-15
Primary Completion
2019-05-14
Completion
2019-05-14

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03561571 on ClinicalTrials.gov